GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 325-332

  Hoskin, Peter J ^a   Colombo, Alessandro ^b   Henry, Ann ^c   Niehoff, Peter ^d   Paulsen Hellebust, Taran ^e   Siebert, Frank Andre ^f   Kovacs, Gyorgy ^g  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b A MANZONI HOSPITAL   (Italy)

^c St James's Institute of Oncology   (United Kingdom)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Brachytherapy; Guidelines; High dose rate; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CATHETERIZATION; DIGITAL RECTAL EXAMINATION; DISEASE FREE SURVIVAL; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FUNCTIONAL ASSESSMENT; GLEASON SCORE; HIGH DOSE RATE AFTERLOADING BRACHYTHERAPY; IMPLANT; MONOTHERAPY; PATIENT SELECTION; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; SEMINAL VESICLE; SEXUAL FUNCTION; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING; TUMOR BIOPSY; URODYNAMICS;

BRACHYTHERAPY; GUIDELINES; HIGH DOSE RATE; PROSTATE CANCER;

BRACHYTHERAPY; HUMANS; MALE; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 84881476975     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.05.002     Document Type: Review

References (52)

1. G. Kovacs, R. Potter, and T. Loch GEC-ESTRO EAU recommendations on temporary brachytherapy using stepping sources for localized prostate cancer Radiother Oncol 74 2005 137 148
2. S.M. Bentzen, and M.A. Roitter The αβ ratio for prostate cancer; what is it really? Radiother Oncol 76 2005 1 3
3. B.J. Davies, E.M. Horwtiz, and W.R. Lee American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy Brachytherapy 11 2012 6 19
4. Y. Yamada, L. Rogers, and D.J. Demanes American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy Brachytherapy 11 2012 20 32
5. P.J. Hoskin, A.M. Rojas, P.J. Bownes, G.J. Lowe, P.J. Ostler, and L. Bryant Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer Radiother Oncol 103 2012 217 222
6. G. Borghede, H. Hedelin, and S. Holmang Irradiation of localised prostate carcinoma with a combination of high dose rate brachytherapy and external beam radiotherapy with three target definitions and dose levels within the prostate gland Radiother Oncol 44 1997 245 250
7. S. Deger, D. Boehmer, and I. Turk High dose rate brachytherapy of localized prostate cancer Eur Urol 41 2002 202 206
8. A.C. Pellizon, W. Nadalin, and A.C. Salvajoli Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer Radiother Oncol 33 2006 167 172
9. J. Hiratsuka, I. Yo, and K. Yoshida Clinical results of combined treatment conformal high-dose-rate iridium 192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer Int J Radiat Oncol Biol Phys 59 2009 684 690
10. P.H. Chiang, F.M. Fang, and W.C. Jong High dose rate iridium brachytherapy and external beam radiation therapy for prostate cancer with or without androgen ablation Int J Urol 11 2004 152 158
11. L. Astrom, D. Pedersen, and C. Mercke Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer Radiother Oncol 74 2005 157 161
12. A.A. Martinez, D.J. Demanes, and R. Galalae Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime Int J Radiat Oncol Biol Phys 62 2005 1322 1331
13. Y. Yamada, S. Bhatia, and M. Zaider Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer Brachytherapy 5 2006 157 164
14. C.E. Vargas, A.A. Martinez, and T.P. Boike High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study Int J Radiat Oncol Biol Phys 66 2006 416 423
15. Y.S. Chin, J. Bullard, and L. Bryant High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer Clin Oncol (R Coll Radiol) 18 2006 474 479
16. T.P. Phan, A.M. Syed, and A. Puthawala High dose rate brachytherapy as a boost for the treatment of localized prostate cancer J Urol 177 2007 123 127
17. Y.C. Chen, C.K. Chuang, and M.L. Hsieh High-dose-rate brachytherapy plus external beam radiotherapy for T1 to T3 prostate cancer: an experience in Taiwan Urology 70 2007 101 105
18. K.M. Kalkner, T. Wahlgren, and M. Ryberg Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up Acta Oncol 46 2007 909 917
19. M. Sato, T. Mori, and S. Shirai High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer Int J Radiat Oncol Biol Phys 72 2008 1002 1009
20. D.J. Demanes, D. Brandt, and L. Schour Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation Am J Clin Oncol 32 2009 342 347
21. D.R. Zwahlen, N. Andreonopoulos, and B. Matheson High dose rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer Brachytherapy 9 2010 27 35
22. R.B. Wilder, G.A. Barme, and R.F. Gilbert Preliminary results in prostate cancer patients treated with high-dose-rate brachytherapy and intensity modulated radiation therapy (IMRT) vs. IMRT alone Brachytherapy 9 2010 e341 e348
23. G. Morton, A. Loblaw, and P. Cheung Is 15 Gy the preferred high dose rate brachytherapy boost dose for prostate cancer? Radiother Oncol 100 2011 463 467
24. T. Kaprealian, V. Weinberg, and J.L. Speight High dose rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes Int J Radiat Oncol Biol Phys 82 2012 222 227
25. B.R. Pieters, J.B. van de Kamer, and Y.R.J. van Herten Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy Radiother Oncol 88 2008 46 52
26. I. Deutsch, M.J. Zelefsky, and Z. Zhang Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT Brachytherapy 9 2010 313 318
27. A. Heidenreich, J. Bellmunt, and M. Bolla EAU guidelines on prostate cancer. Part 1: Screening, diagnosis and treatment of clinically localized disease Eur Urol 59 2011 61 71
28. A. Briganti, N. Passoni, and M. Ferrari When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool Eur Urol 57 2010 551 558
29. M.S. Katz, J.A. Efstathiou, and A.V. D'Amico The 'CaP calculator' an online decision support tool for clinically localized prostate cancer BJU Int 105 2010 1417 1422
30. C.J. DiBlasio, A.C. Rhee, D. Cho, P.T. Scardino, and M. Kattan Predicting clinical endpoints: treatment nomograms in prostate cancer Semin Oncol 30 2003 567 586
31. K. Bouchelouch, and P. Oehr Positron emission tomography and poitron emission/computerised tomography of urological malignancies: an update review J Urol 179 2008 34 39
32. A.T. Monroe, P.O. Faricy, and S.B. Jennings High dose rate brachytherapy for large prostate volumes (≥50 cc) - uncompromised dosimetric coverage and acceptable toxicity Brachytherapy 7 2008 7 11
33. B. Pieters, J. Van der Grient, L. Blank, K. Koedooder, M. Hulshof, and T. Reijke Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants Radiother Oncol 80 2006 69 72
34. G. Kertzscher, C.E. Andersen, F.A. Siebert, S.K. Nielsen, J.C. Lindegaard, and K. Tanderup Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion Radiother Oncol 100 2011 456 462
35. A.A. Martinez, J. Gonzalez, and H. Ye Dose escalation improves cancer related events at 10 years for intermediate and high risk prostate cancer patients treated with hypofractionated high dose rate boost and external beam radiotherapy Int J Radiat Oncol Biol Phys 79 2011 363 370
36. G. Morton, A. Loblaw, and P. Cheung Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer? Radiother Oncol 100 2011 463 467
37. Y. Yoshioka, K. Komishi, and Y. Somida Monotherapeutic high dose rate brachytherapy for prostate cancer: five year results of an extreme hypofractionation regimen with 54 Gy in nine fractions Int J Radiat Oncol Biol Phys 80 2011 469 475
38. D.J. Demanes, A. Martinez, and M. Ghilzean High dose rate monotherapy; safe and effective brachytherapy for patients with localized prostate cancer Int J Radiat Oncol Biol Phys 81 2011 1286 1292
39. M. Ghilzean, G. Gustason, and D. Kraus High dose rate brachytherapy delivered as two fractions within one day for favorable/intermediate risk prostate cancer. Preliminary toxicity data Int J Radiat Oncol Biol Phys 83 2012 927 932
40. P. Hoskin, A.M. Rojas, and G. Lowe High dose rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence Int J Radiat Oncol Biol Phys 82 2012 1376 1384
41. C.L. Roger, A.S. Alders, and R.L. Rogers High dose rate brachytherapy as monotherapy for intermediate risk prostate cancer J Urol 187 2012 109 116
42. M. Barkati, S. Williams, and F. Faroudi High dose rate brachytherapy as monotherapy for favourable risk prostate cancer: a phase II trial Int J Radiat Oncol Biol Phys 82 2012 1889 1896
43. P.J. Prada, I. JIminez, and H. Gonzales-Suarez High dose rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favourable stage prostate cancer: treatment prescription and preliminary results Brachytherapy 11 2012 105 110
44. B. Lee, K. Shinohara, and V. Weinberg Feasibility of high dose rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of San Francisco experience Int J Radiat Oncol Biol Phys 67 2007 1106 1112
45. M. Tharp, M. Hardacre, and R. Bennett Prostate high dose rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer Brachytherapy 7 2008 231 236
46. P. Niehoff, T. Loch, and N. Nurnberg Feasibility and preliminary outcome of salvage combined brachytherapy and external beam radiotherapy for local recurrences after radical prostatectomy Brachytherapy 4 2005 141 145
47. R. Potter, C. Haie Meder, and E. van Limbergen Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy - 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77
48. D. Baltas, C. Kolotas, and K. Geramani A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy Int J Radiat Oncol Biol Phys 40 1998 515 524
49. R. Nath, L.L. Anderson, and G. Luxton Dosimetry of interstitial brachytherapy sources; recommendations of the AAPM Radiation Therapy Committee Task group No 43 American Association of Physicists in medicine Med Phys 22 1995 209 234
50. International Commission on Radiation Units and Measurement (ICRU) Dose and volume specification for reporting interstitial therapy. Report No 58 of ICRU 1997 ICRU Publications Bethesda (MD)
51. C.C. Ling, J. Humm, and S. Larson Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551 560
52. U. Schick, Y. Popowski, and P. Nouet High dose rate brachytherapy boost to the dominant intraprostatic tumour region: hemi-irradiation of prostate cancer Prostate 2011 10.1002/pros.21347